title: Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis.
authors.affiliation: Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Keiichi
authors.initials: K
authors.lastname: Sakurai
authors.affiliation: Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Kanae
authors.initials: K
authors.lastname: Kubo
authors.affiliation: Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Kanda
authors.affiliation: Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Keishi
authors.initials: K
authors.lastname: Fujio
authors.affiliation: Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Yamamoto
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000276:immunology*; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004351:Drug Resistance; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D055953:Microscopic Polyangiitis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D003520:Cyclophosphamide; D016559:Tacrolimus